Ukrainian CheckEye Joins Plug and Play Accelerator in Uzbekistan
Ukrainian startup CheckEye, which develops AI-based technology for detecting diseases through blood vessel analysis, has joined the Plug and Play Tech Center accelerator program in Uzbekistan, the company told Scroll.media.
- A total of 17 startups, including CheckEye, were accepted into the program. The accelerator partners with IT PARK Uzbekistan and the Ministry of Digital Technologies of the Republic of Uzbekistan.
- Plug and Play is one of the world’s most renowned innovation networks, with a presence in more than 30 locations and over 125 accelerators globally. Each program focuses on a specific industry, such as fintech, medtech, or mobility. зосереджена на певній галузі — такій як фінтех, медичні технології чи мобільність.
- The network’s portfolio includes over 2,000 startups that have collectively raised over $12 billion in investments. Its ecosystem connects founders with over 300 venture investors who can finance accelerator participants.
- Typically, Plug and Play invests between $25,000 and $500,000, depending on the startup’s stage and needs. However, CheckEye clarified to Scroll.media that this particular program does not provide direct funding. Still, it offers a valuable opportunity for startups to enter the fast-growing Central Asian market.
Why Uzbekistan?
Several key factors make Uzbekistan an attractive location, explains Anastasiia Kyrylenko, Head of Operations at CheckEye:
«The country has a very high prevalence of diabetes and related complications, particularly retinopathy, while the healthcare system struggles with overload and a lack of regular preventive screening. For CheckEye, this creates a unique opportunity to demonstrate how our technology performs in real-world conditions, where there’s a huge need for early detection of chronic diseases and limited resources for traditional diagnostic programs.
In addition, Uzbekistan is actively investing in digital health and building partnerships with international innovation organizations. Plug and Play, together with local partners, is creating a favorable environment for pilot projects, so participation in this accelerator opens the door for our technology to reach the broader Central Asian market.»
Over the past two years, CheckEye has raised $700,000 in investments. In 2024, the startup entered the German market with its AI-powered screening tool and is now preparing to scale across the European Union.
In an interview with Scroll.media, founder Kyrylo Honcharuk shared how CheckEye was founded, what sets it apart, and how the raised funds were used to advance its mission.
Ukrainian CheckEye Joins Plug and Play Accelerator in Uzbekistan
Ukrainian startup CheckEye, which develops AI-based technology for detecting diseases through blood vessel analysis, has joined the Plug and Play Tech Center accelerator program in Uzbekistan, the company told Scroll.media.
- A total of 17 startups, including CheckEye, were accepted into the program. The accelerator partners with IT PARK Uzbekistan and the Ministry of Digital Technologies of the Republic of Uzbekistan.
- Plug and Play is one of the world’s most renowned innovation networks, with a presence in more than 30 locations and over 125 accelerators globally. Each program focuses on a specific industry, such as fintech, medtech, or mobility. зосереджена на певній галузі — такій як фінтех, медичні технології чи мобільність.
- The network’s portfolio includes over 2,000 startups that have collectively raised over $12 billion in investments. Its ecosystem connects founders with over 300 venture investors who can finance accelerator participants.
- Typically, Plug and Play invests between $25,000 and $500,000, depending on the startup’s stage and needs. However, CheckEye clarified to Scroll.media that this particular program does not provide direct funding. Still, it offers a valuable opportunity for startups to enter the fast-growing Central Asian market.
Why Uzbekistan?
Several key factors make Uzbekistan an attractive location, explains Anastasiia Kyrylenko, Head of Operations at CheckEye:
«The country has a very high prevalence of diabetes and related complications, particularly retinopathy, while the healthcare system struggles with overload and a lack of regular preventive screening. For CheckEye, this creates a unique opportunity to demonstrate how our technology performs in real-world conditions, where there’s a huge need for early detection of chronic diseases and limited resources for traditional diagnostic programs.
In addition, Uzbekistan is actively investing in digital health and building partnerships with international innovation organizations. Plug and Play, together with local partners, is creating a favorable environment for pilot projects, so participation in this accelerator opens the door for our technology to reach the broader Central Asian market.»
Over the past two years, CheckEye has raised $700,000 in investments. In 2024, the startup entered the German market with its AI-powered screening tool and is now preparing to scale across the European Union.
In an interview with Scroll.media, founder Kyrylo Honcharuk shared how CheckEye was founded, what sets it apart, and how the raised funds were used to advance its mission.
